1. Home
  2. AMRX vs RXRX Comparison

AMRX vs RXRX Comparison

Compare AMRX & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMRX
  • RXRX
  • Stock Information
  • Founded
  • AMRX 2002
  • RXRX 2013
  • Country
  • AMRX United States
  • RXRX United States
  • Employees
  • AMRX N/A
  • RXRX N/A
  • Industry
  • AMRX Biotechnology: Pharmaceutical Preparations
  • RXRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMRX Health Care
  • RXRX Health Care
  • Exchange
  • AMRX Nasdaq
  • RXRX Nasdaq
  • Market Cap
  • AMRX 2.4B
  • RXRX 2.6B
  • IPO Year
  • AMRX N/A
  • RXRX 2021
  • Fundamental
  • Price
  • AMRX $8.38
  • RXRX $5.29
  • Analyst Decision
  • AMRX Strong Buy
  • RXRX Buy
  • Analyst Count
  • AMRX 5
  • RXRX 4
  • Target Price
  • AMRX $10.80
  • RXRX $8.25
  • AVG Volume (30 Days)
  • AMRX 1.8M
  • RXRX 17.5M
  • Earning Date
  • AMRX 05-02-2025
  • RXRX 05-08-2025
  • Dividend Yield
  • AMRX N/A
  • RXRX N/A
  • EPS Growth
  • AMRX N/A
  • RXRX N/A
  • EPS
  • AMRX N/A
  • RXRX N/A
  • Revenue
  • AMRX $2,793,957,000.00
  • RXRX $58,839,000.00
  • Revenue This Year
  • AMRX $10.49
  • RXRX $64.84
  • Revenue Next Year
  • AMRX $7.00
  • RXRX $55.98
  • P/E Ratio
  • AMRX N/A
  • RXRX N/A
  • Revenue Growth
  • AMRX 16.73
  • RXRX 32.00
  • 52 Week Low
  • AMRX $5.18
  • RXRX $5.19
  • 52 Week High
  • AMRX $9.48
  • RXRX $12.36
  • Technical
  • Relative Strength Index (RSI)
  • AMRX 46.15
  • RXRX 33.28
  • Support Level
  • AMRX $8.18
  • RXRX $6.27
  • Resistance Level
  • AMRX $8.95
  • RXRX $6.94
  • Average True Range (ATR)
  • AMRX 0.31
  • RXRX 0.38
  • MACD
  • AMRX -0.08
  • RXRX -0.06
  • Stochastic Oscillator
  • AMRX 23.40
  • RXRX 5.71

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About RXRX Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.

Share on Social Networks: